Devin T. Corrigan

24 posts

Devin T. Corrigan banner
Devin T. Corrigan

Devin T. Corrigan

@DevinTCorrigan

PhD candidate in the Zang lab studying novel immune checkpoints and making immunotherapies • NYC • CAR-T cells • Antibodies • Cancer

New York, NY Katılım Şubat 2021
63 Takip Edilen24 Takipçiler
Devin T. Corrigan retweetledi
NextPoint Therapeutics
NextPoint Therapeutics@NextPointTX·
Exciting Preclinical Data on Our Novel B7-H7 T Cell Engager Announced at #SITC2024! This innovative approach shows promise in overcoming the tumor microenvironment challenges. Can't join us in Houston? Explore the details here: bit.ly/3Angf5E
NextPoint Therapeutics tweet media
English
0
1
1
51
Devin T. Corrigan
Devin T. Corrigan@DevinTCorrigan·
Last week I was honored to receive the Barry R. Bloom speaker award for the top Work-in-Progress presentation in the Microbiology and Immunology department. Thank you to my mentor @xingxing_zang for all of your support and guidance! @EinsteinMed @EinsteinPhD
Devin T. Corrigan tweet media
English
2
1
10
941
Devin T. Corrigan retweetledi
Albert Einstein College of Medicine - Official
Immunotherapy has revolutionized cancer care. Now @theNCI-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) has announced the new Marilyn and Stanley M. Katz Institute for Immunotherapy for Cancer and Inflammatory Disorders. More at bit.ly/3B5vlwl. 1/2
Albert Einstein College of Medicine - Official tweet media
English
1
5
9
2.3K
Devin T. Corrigan retweetledi
XingXing Zang
XingXing Zang@xingxing_zang·
Nice annual scientific retreat of Montefiore Einstein Comprehensive Cancer Center at the beautiful Glen Island Harbour Club.
XingXing Zang tweet mediaXingXing Zang tweet mediaXingXing Zang tweet mediaXingXing Zang tweet media
English
0
6
17
1.8K
Devin T. Corrigan retweetledi
XingXing Zang
XingXing Zang@xingxing_zang·
My thoughts on Chimeric Antigen Receptor (CAR) immune-cell therapy. The next frontier for CAR therapy is solid cancers and autoimmune diseases, also holds promises for aging, Alzheimer’s disease, etc. The Next Chapter of Science | Technology Networks technologynetworks.com/informatics/ar…
English
0
3
8
561
Devin T. Corrigan retweetledi
XingXing Zang
XingXing Zang@xingxing_zang·
Grateful Oscar Ortiz from SebastianStrong Foundation came to my office and present a check for our CAR research. My lab, David Loeb and Allison Martin are developing next-generation CAR-T therapy treating human pediatric Rhabdomyosarcoma. @EinsteinMed @MontefioreNYC
XingXing Zang tweet mediaXingXing Zang tweet media
English
2
3
23
2.5K
Devin T. Corrigan retweetledi
XingXing Zang
XingXing Zang@xingxing_zang·
Great congratulations to NextPoint!!!  It took 10 years moving from our original discovery of HHLA2 as a new B7 immune checkpoint in 2013 to NextPoint’s soon clinical trials in cancer patients. @EinsteinMed @MontefioreNYC
NextPoint Therapeutics@NextPointTX

We received FDA acceptance of our investigational new drug (IND) application to advance NPX887, a monoclonal antibody targeting HHLA2 that is designed to enhance immune responses in the tumor microenvironment. Read more at nextpointtx.com.

English
3
3
10
1.1K
Devin T. Corrigan retweetledi
XingXing Zang
XingXing Zang@xingxing_zang·
Thrilled to share a new paper on @Dev_Cell from a fruitful collaboration between @WenjunGuoLab and my lab, showing the Sox9-B7x pathway in @breastcancer immune evasion and a potential new @immunotherapy. @EinsteinCellBio @EinsteinMed @MontefioreNYC
Developmental Cell@Dev_Cell

Online now: A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression dlvr.it/Syn1PP

English
6
10
37
4.3K
CNN Breaking News
CNN Breaking News@cnnbrk·
At least six people are dead and seven injured after a shooting in Hamburg, Germany, local media say. The suspects are reportedly still at large. cnn.it/3mwFqv0
English
89
221
391
661.4K